Create issue ticket

503 Possible Causes for Non-Alcoholic Fatty Liver Disease

  • Insulin Resistance

    We hypothesize the co-factorial role of H. pylori in the mechanisms involved in non-alcoholic fatty liver disease pathogenesis and insulin resistance, by the cytokine serum[] BACKGROUNDS AND AIMS: Non-alcoholic fatty liver disease (NAFLD) is associated with insulin resistance (IR).[] Abstract Insulin resistance is associated with a poor prognosis in nonalcoholic fatty liver disease (NAFLD) patients.[]

  • Alcoholic Liver Disease

    ), chronic hepatitis C virus (HCV) infection (n 145) or non-alcoholic fatty liver disease (NAFLD) (n 78).[] AIM: To evaluate a calcium activated potassium channel (KCa3.1) inhibitor attenuates liver disease in models of non-alcoholic fatty liver disease (NAFLD).[] BACKGROUND: This study evaluates long-term outcomes and body mass index (BMI) following liver transplantation (LT) for non-alcoholic fatty liver disease (NAFLD) in comparison[]

  • Ascites

    diseases (non-alcoholic fatty liver disease, alcoholic liver disease, and chronic hepatitis C) develop cirrhosis over a period of 10–20 years.[] There are a wide variety of causing liver tissue damaged such as alcoholic cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), hepatocellular carcinoma to name[] With a rising frequency of alcoholic and non-alcoholic fatty liver disease, a huge increase in the burden of liver disease is expected over the next few years with an inevitable[]

  • Metabolic Syndrome

    Diagnosis of non-alcoholic fatty liver disease was done by liver imaging and based on liver enzymes.[] A Single Non-invasive Model to Diagnose Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH).[] Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.[]

  • Cryptogenic Cirrhosis

    Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease offers hepatologists practical, up-to-date and expert guidance on the most topical dilemmas, difficulties and areas[] BACKGROUND/AIMS: Non-alcoholic fatty liver disease (NAFLD) and cryptogenic cirrhosis (CC), which is largely a late sequela of NAFLD, are considered pre-neoplastic conditions[] Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.[]

  • Malignant Hepatic Neoplasm

    Cirrhosis can be the result of hepatitis B or C infection, heavy alcohol use, non-alcoholic fatty liver disease and autoimmune liver disorders.[] non-alcoholic fatty liver disease.[] […] cancer is cirrhosis due to hepatitis B, hepatitis C or alcohol. [4] Other causes include aflatoxin, non-alcoholic fatty liver disease and liver flukes. [3] The most common[]

  • Fatty Liver

    Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease from fatty liver to non-alcoholic steatohepatitis, fibrosis, and cirrhosis.[] Keywords Non-alcoholic steatohepatitis Lipotoxicity De novo lipogenesis Fibrogenesis Insulin resistance Fatty acids Background Non-alcoholic fatty liver disease (NAFLD) has[] NAFLD, non-alcoholic fatty liver disease ALT, alanine aminotransferase AST, aspartate aminotransferase NASH, non-alcoholic steatohepatitis non-alcoholic fatty liver disease[]

  • Lipodystrophy

    Identifying drug targets for non-alcoholic fatty liver disease is under active investigation.[] PARTICIPANTS: Twenty-three patients (22 with familial, one acquired, 78·3% female, aged 12-64 years) with PL and non-alcoholic fatty liver disease (NAFLD).[] The absence of fat tissue is associated with insulin resistance, hypertriglyceridemia, non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome.[]

  • Generalized Lipodystrophy

    ), non-alcoholic fatty liver disease (NAFLD), and common obesity.[] fatty liver disease.[] Its efficacy as hormone replacement therapy suggests broader applications in diseases also characterized by leptin abnormalities, such as familial partial lipodystrophy (FPLD[]

  • Liver Disease

    Non-alcoholic fatty liver disease (NAFLD) is the commonest cause of chronic liver disease in the Australian population, although precise estimates of prevalence are lacking[] Abstract Non-alcoholic fatty liver disease (NAFLD) is currently the world's most common liver disease, estimated to affect up to one-fourth of the population.[] Non-alcoholic fatty liver disease (NAFLD) is the term for a range of conditions caused by a build-up of fat in the liver.[]

Further symptoms